TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
GSK

GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ -0.4% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns GlaxoSmithKline PLC (GSK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.9% of the shares are freely tradable; institutional investors hold 18.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 18.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 96.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 2,005Mio.

Largest Shareholders

Institutions

Institutions GSK
Name Stake (%) Shares Change (%) Date
FMR Inc 3.24 64,961,641 -4.0 06/30/2026
Dodge & Cox 2.40 48,197,514 -17.8 06/30/2026
Fisher Asset Management, LLC 1.78 35,722,792 +3.5 06/30/2026
PRIMECAP Management Company 1.26 25,182,068 -0.1 06/30/2026
Wellington Management Company LLP 0.57 11,396,249 -2.7 06/30/2026
JTC Employer Solutions Trustee Ltd 0.43 8,592,987 -5.0 06/30/2026

Funds

Funds GSK
Name Stake (%) Shares Change (%) Date
Dodge & Cox Stock I 1.51 30,275,877 -10.4 09/30/2026
Vanguard PRIMECAP Inv 0.91 18,211,650 +0.2 09/30/2026
Vanguard Wellington Inv 0.43 8,636,463 -10.6 09/30/2026
Strategic Advisers Fidelity US TtlStk 0.40 8,053,827 +0.4 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?